Immediate Impact

3 by Nobel laureates 53 standout
Sub-graph 1 of 25

Citing Papers

Targeting the Warburg Effect in Cancer: Where Do We Stand?
2024 Standout
Non-small-cell lung cancer
2024 Standout
3 intermediate papers

Works of Marcus Stockinger being referenced

Thoracic radiotherapy PLUS durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy: Employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy—The TRADE-hypo trial.
2021
Overexpression of GLUT-1 is associated with resistance to radiotherapy and adverse prognosis in squamous cell carcinoma of the oral cavity
2007
and 1 more

Author Peers

Author Last Decade Papers Cites
Marcus Stockinger 69 123 58 131 74 19 301
Hooney Min 117 103 81 143 107 12 368
Zhenyu Qi 94 65 47 74 58 19 345
Mersiha Hadziahmetovic 69 35 99 81 51 16 321
Xiangshan Yang 67 72 32 132 76 21 288
Özge Petek Erpolat 79 62 86 76 91 25 293
Junko Zenkoh 40 43 132 132 69 18 326
Xinqiong Huang 45 141 25 170 110 17 345
Shane S. Neibart 47 38 69 91 60 23 328
Elisa Lodi Rizzini 67 33 81 85 78 22 344
Mau‐Shin Chi 58 60 22 109 54 16 303

All Works

Loading papers...

Rankless by CCL
2026